30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Dan Bradbury

Track

Insider profile

Currently holds positions in Equillium Inc, Castle Biosciences Inc, Intercept Pharmaceuticals Inc, Biocon Ltd and Syngene International Ltd

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return 5% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Executive Chairman of the Board Equillium Inc Jan. 1, 2020 -
Independent Chairman of the Board Castle Biosciences Inc Sept. 1, 2014 -
Independent Director Intercept Pharmaceuticals Inc July 1, 2016 -
Non-Executive Independent Director Biocon Ltd April 25, 2013 -
Non-Executive Independent Director Syngene International Ltd None -
Chairman of the Board, Chief Executive Officer Equillium Inc June 1, 2018 - Jan. 1, 2020
Independent Director Corcept Therapeutics Inc Oct. 10, 2012 - June 18, 2019
Independent Director Geron Corp Sept. 26, 2012 - May 14, 2019
Chairman of the Board Equillium Inc March 1, 2017 - June 1, 2018
Independent Director Illumina Inc Jan. 1, 2004 - May 30, 2017
Lead Independent Director BioMed Realty Trust Inc Feb. 1, 2015 - Jan. 27, 2016
Director BioMed Realty Trust Inc Jan. 1, 2013 - Feb. 1, 2015
President, Chief Executive Officer, Director Amylin Pharmaceuticals LLC March 1, 2007 - Aug. 8, 2012
Dan Bradbury's trades of Castle Biosciences Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-07 2025-02-05
PlS Planned sale
58,641 -32.6%
177.74
US$2,811,708 		58,641 -32.6% 177.74 US$2,811,708
2025-02-07 2025-02-05
PlS Planned sale
15,356 +16.9%
225.10
US$4,180,049 		15,356 +16.9% 225.10 US$4,180,049
2025-02-07 2025-02-05
PlS Planned sale
41,878 -19.7%
191.09
US$1,303,698 		41,878 -19.7% 191.09 US$1,303,698
2025-02-05 2025-02-05
PrS Proposed sale
7,867
28.12
US$221,220 		7,867 28.12 US$221,220
2025-01-08 2025-01-06
PlS Planned sale
134 -8.6%
29.82
US$3,996 		134 -8.6% 29.82 US$3,996
2025-01-08 2025-01-06
PlS Planned sale
134 -8.6%
29.82
US$3,996 		134 -8.6% 29.82 US$3,996
2025-01-08 2025-01-06
PlS Planned sale
472 -8.6%
29.82
US$14,075 		472 -8.6% 29.82 US$14,075
2025-01-08 2025-01-06
PlS Planned sale
857 -35.5%
29.41
US$25,204 		857 -35.5% 29.41 US$25,204
2025-01-08 2025-01-06
PlS Planned sale
857 -35.5%
29.41
US$25,204 		857 -35.5% 29.41 US$25,204
2025-01-08 2025-01-06
PlS Planned sale
3,015 -35.5%
29.41
US$88,671 		3,015 -35.5% 29.41 US$88,671
2025-01-08 2025-01-06
PlS Planned sale
434 -15.2%
28.39
US$12,321 		434 -15.2% 28.39 US$12,321
2025-01-08 2025-01-06
PlS Planned sale
434 -15.2%
28.39
US$12,321 		434 -15.2% 28.39 US$12,321
2025-01-08 2025-01-06
PlS Planned sale
1,530 -15.2%
28.39
US$43,437 		1,530 -15.2% 28.39 US$43,437
2024-12-05 2024-12-03
PlS Planned sale
99 -3.4%
31.32
US$3,101 		99 -3.4% 31.32 US$3,101
2024-12-05 2024-12-03
PlS Planned sale
99 -3.4%
31.32
US$3,101 		99 -3.4% 31.32 US$3,101
2024-12-05 2024-12-03
PlS Planned sale
348 -3.4%
31.32
US$10,899 		348 -3.4% 31.32 US$10,899
2024-12-05 2024-12-03
PlS Planned sale
1,326 -31.0%
30.95
US$41,041 		1,326 -31.0% 30.95 US$41,041
2024-12-05 2024-12-03
PlS Planned sale
1,326 -31.0%
30.95
US$41,041 		1,326 -31.0% 30.95 US$41,041
2024-12-05 2024-12-03
PlS Planned sale
4,669 -31.0%
30.95
US$144,510 		4,669 -31.0% 30.95 US$144,510
2024-12-03 2024-12-03
PrS Proposed sale
15,734
30.78
US$484,293 		15,734 30.78 US$484,293
2024-11-05 2024-11-01
PlS Planned sale
287 -6.3%
35.33
US$10,140 		287 -6.3% 35.33 US$10,140
2024-11-05 2024-11-01
PlS Planned sale
287 -6.3%
35.33
US$10,140 		287 -6.3% 35.33 US$10,140
2024-11-05 2024-11-01
PlS Planned sale
1,009 -6.3%
35.33
US$35,648 		1,009 -6.3% 35.33 US$35,648
2024-11-05 2024-11-01
PlS Planned sale
763 -14.3%
34.92
US$26,644 		763 -14.3% 34.92 US$26,644
2024-11-05 2024-11-01
PlS Planned sale
763 -14.3%
34.92
US$26,644 		763 -14.3% 34.92 US$26,644
2024-11-05 2024-11-01
PlS Planned sale
2,686 -14.3%
34.92
US$93,795 		2,686 -14.3% 34.92 US$93,795
2024-11-05 2024-11-01
PlS Planned sale
375 -6.6%
33.90
US$12,712 		375 -6.6% 33.90 US$12,712
2024-11-05 2024-11-01
PlS Planned sale
375 -6.6%
33.90
US$12,712 		375 -6.6% 33.90 US$12,712
2024-11-05 2024-11-01
PlS Planned sale
1,322 -6.6%
33.90
US$44,816 		1,322 -6.6% 33.90 US$44,816
2024-10-09 2024-10-07
PlS Planned sale
1,425 -20.0%
29.44
US$41,956 		1,425 -20.0% 29.44 US$41,956
2024-10-09 2024-10-07
PlS Planned sale
1,425 -20.0%
29.44
US$41,956 		1,425 -20.0% 29.44 US$41,956
2024-10-09 2024-10-07
PlS Planned sale
5,017 -20.0%
29.44
US$147,716 		5,017 -20.0% 29.44 US$147,716
2024-10-07 2024-10-07
PrS Proposed sale
15,734
29.52
US$464,468 		15,734 29.52 US$464,468
2024-09-09 2024-09-05
PlS Planned sale
1,425 -16.7%
29.02
US$41,359 		1,425 -16.7% 29.02 US$41,359
2024-09-09 2024-09-05
PlS Planned sale
1,425 -16.7%
29.02
US$41,359 		1,425 -16.7% 29.02 US$41,359
2024-09-09 2024-09-05
PlS Planned sale
5,017 -16.7%
29.02
US$145,613 		5,017 -16.7% 29.02 US$145,613
2024-08-14 2024-08-12
PlS Planned sale
1,431 -14.3%
26.65
US$38,132 		1,431 -14.3% 26.65 US$38,132
2024-08-14 2024-08-12
PlS Planned sale
1,431 -14.3%
26.65
US$38,132 		1,431 -14.3% 26.65 US$38,132
2024-08-14 2024-08-12
PlS Planned sale
5,021 -14.3%
26.65
US$133,795 		5,021 -14.3% 26.65 US$133,795
2024-08-12 2024-08-12
PrS Proposed sale
15,750
26.75
US$421,312 		15,750 26.75 US$421,312
2024-05-08 2024-05-06
PlS Planned sale
7,967 -44.4%
24.64
US$196,307 		7,967 -44.4% 24.64 US$196,307
2024-05-08 2024-05-06
PlS Planned sale
7,963 -44.4%
24.64
US$196,208 		7,963 -44.4% 24.64 US$196,208
2024-05-08 2024-05-06
PlS Planned sale
7,393 -17.4%
24.64
US$182,164 		7,393 -17.4% 24.64 US$182,164
2024-04-10 2024-04-08
PlS Planned sale
820 -4.4%
20.45
US$16,771 		820 -4.4% 20.45 US$16,771
2024-04-10 2024-04-08
PlS Planned sale
819 -4.4%
20.45
US$16,751 		819 -4.4% 20.45 US$16,751